Dendritic cell paucity in mismatch repair–proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacyWilliam W. Ho, Rakesh K. Jain, Igor L. Gomes‐Santos et al.|Proceedings of the National Academy of Sciences|2021Cited by 91
Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic CancerYves Boucher, Rakesh K. Jain, Jessica M. Posada et al.|Clinical Cancer Research|2023Cited by 53
IMMUNE-MEDIATED MYOCARDITIS FOLLOWING SINGLE DOSE OF ADJUVANT ATEZOLIZUMAB: DOES BENEFIT OUTWEIGH RISK?Ashwin S. Kumar, Ana Barac, Harjit Singh et al.|Journal of the American College of Cardiology|2023Cited by 1
TMIC-61. LOSARTAN PREVENTS IMMUNOTHERAPY-ASSOCIATED EDEMA AND ENHANCES SURVIVAL IN GLIOBLASTOMAMeenal Datta, Kamila Naxerova, Ashwin S. Kumar et al.|Neuro-Oncology|2022Cited by 0